Radius Health (NASDAQ:RDUS) had its price target decreased by stock analysts at Jefferies Group from $79.00 to $77.00 in a note issued to investors on Wednesday, StockTargetPrices.com reports. Jefferies Group’s price target would suggest a potential upside of 25.18% from the stock’s previous close. In other Radius Health news, major shareholder Growth N. V. Biotech […]
